ABCLON
AbClon Inc. engages in the research and development of antibody drugs in South Korea and Sweden.
ABCLON
Industry:
Biotechnology Health Care Information Technology Therapeutics
Founded:
2010-01-01
Address:
Seoul, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Website Url:
http://www.abclon.com
Total Employee:
11+
Status:
Active
Contact:
02-2109-1294
Email Addresses:
[email protected]
Similar Organizations
Animal Cell Therapies
Animal Cell Therapies engages in the research and development of stem cell treatments for acute and chronic diseases in companion animals.
BociMed
BociMed is a company engaged in drug research and development and clinical research.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Lukas Biomedical
Lukas Biomedical engages in the research and development of immunotherapy for cancer treatment.
Restyro technologies
Restyro technologies is a start-up company focused on the research and development of polymer nanofibres based technology and products
Official Site Inspections
http://www.abclon.com Semrush global rank: 10.02 M Semrush visits lastest month: 62
- Host name: 210.114.6.201
- IP address: 210.114.6.201
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
More informations about "AbClon"
Abclon
AbClon announced on the 2nd that its CAR-T (Chimeric Antigen Receptor T-cell) therapy AT101 has been approved by the World Health Organization (WHO) with the International Nonproprietary Name (INN) 'Nespecabtagene autoleucelโ โฆSee details»
AbClon - Crunchbase Company Profile & Funding
Organization. AbClon . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. AbClon Inc. engages in the research and โฆSee details»
Organization: AbClon - Cbonds.com
Organization: AbClon Organization name. AbClon Inc. Country name. Republic of Korea ... AbClon Inc develops antibody drugs for the treatment of stomach, colorectal, and lung cancer. โฆSee details»
AbClon (KOSDAQ:174900) Company Profile & Description - Stock โฆ
4 days ago AbClon Inc. engages in the research and development of antibody drugs in South Korea and Sweden. The companyโs products in pipeline include NEST platform technology โฆSee details»
Company AbClon Inc. - MarketScreener.com
Business description: AbClon Inc. AbClon Inc. is a Korea-based company principally engaged in the development, manufacture and distribution of antibody drug. The Company developed a โฆSee details»
AbClon Inc - VentureRadar
Website: https://www.abclon.com. Develops cutting-edge therapeutic platforms including CAR-T therapy, NEST technology for novel antibodies, and AffiMab for dual-target antibodies to treat โฆSee details»
AbClon Company Profile - Office Locations, Competitors, Revenue โฆ
Oct 29, 2024 AbClon โฉ3.08 b in annual revenue in FY 2023. See insights on AbClon including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
AbClon - LinkedIn
AbClon | 31 followers on LinkedIn. AbClon pioneers antibody therapeutics and cell therapy for intractable diseases, advancing global health and hope.See details»
BQURA | Companies - AbClon
AbClon #1401, 285, Digital-ro, Guro-gu, Seoul, Korea. Update Date : 2025-04-15. Send Inquiry. Company information. Related News. Introduction. AbClon specializes in developing antibody โฆSee details»
AbClon Inc - Company Profile and News - Bloomberg Markets
Company profile page for AbClon Inc including stock price, company news, executives, board members, and contact informationSee details»
Abclon - History
AbClon Inc. #1401 285, Digital-ro, Guro-gu, Seoul, Republic of Korea T. +82-2109-1294 F. +82-2109-1296 E. [email protected]; About us. Overview CAR-T GMP History Collaboration Contact Us. Technology. CAR-T platform NEST โฆSee details»
AbClon Signs Agreement with Contract Research Organization โฆ
Oct 30, 2019 AbClon Signs Agreement with Contract Research Organization (CRO) for Blood Cancer CAR-T Treatment Seoul, Korea, March 20, 2019 -- AbClon announced the signing of โฆSee details»
AbClon - Crunchbase Company Profile & Funding
Organization. AbClon . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. AbClon develops antibodies for therapeutics and life science โฆSee details»
AbClon - Updates, News, Events, Signals & Triggers - Crunchbase
AbClon Inc. engages in the research and development of antibody drugs in South Korea and Sweden. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log โฆSee details»
AbClon - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Sep 29, 2022: Convertible โฆSee details»
AbClon - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Mar 10, 2025 AbClon Inc. engages in the research and development of antibody drugs in South Korea and Sweden. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. โฆSee details»
Metro Vancouver has 41 directors. After a governance review
19 hours ago After a year of upheaval and reviews, Metro Vancouver directors are awaiting a report that could tweak a few parts of the biggest regional government in B.C. โ or could โฆSee details»
์ฑํด๋ก (์ฃผ) - AbClon
์ฑํด๋ก (์ฃผ) ์์ธํน๋ณ์ ๊ตฌ๋ก๊ตฌ ๋์งํธ๋ก 285 (๊ตฌ๋ก๋, ์์ด์คํธ์ํ์1์ฐจ) 14์ธต T. 02-2109-1294 F. 02-2109-1296 E. [email protected]See details»
News - AbClon
๋ฒํธ: ์ ๋ชฉ: ๋ ์ง: ์กฐํ: 164 AbClon, The CAR-T cell therapy AT101 'Nespe-cel' has been ofโฆ AbClon announced on the 2nd that its CAR-T (Chimeric Antigen Receptor T-cell) therapy โฆSee details»
์ฑํด๋ก (์ฃผ) - ์ฐํ - AbClon
์ฒจ๋จ ์ธํฌ์ ์ ์ ์น๋ฃ์ ํ๋ซํผ์ ๊ฐ๋ฐํ์ฌ ๊ฐ ์ข ์์ ์น๋ฃํ๋ ๊ธฐ์ ์ ๋ณด์ ํ ์ฑํด๋ก ์ ํญ์ฒด ์ ์ฝ๊ฐ๋ฐ์ ์ ๋์ฃผ์๋ก ํ๊ตญ์ ๊ณผํ์ ๊ทธ๋ฃน๊ณผ ์ค์จ๋ด ๊ณผํ์์ ํจ๊ป 2010๋ ์ค๋ฆฝ๋ ๋ฐ์ด์ค โฆSee details»